Format
Sort by

Send to:

Choose Destination

Search results

Items: 3

1.

The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.

Khamduang W, Jourdain G, Sirirungsi W, Layangool P, Kanjanavanit S, Krittigamas P, Pagdi K, Somsamai R, Sirinontakan S, Hinjiranandana T, Ardonk W, Hongsiriwon S, Nanta S, Borkird T, Lallemant M, McIntosh K, Ngo-Giang-Huong N; Program for HIV Prevention and Treatment (PHPT) Study Group.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):188-92. doi: 10.1097/QAI.0b013e31822d0433.

2.

Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand.

Briand N, Le Coeur S, Jourdain G, Hotrawarikarn S, Sirinontakan S, Hinjiranandana T, Kanjanavanit S, Traisathit P, McIntosh K, Lallemant M; Program for HIV Prevention and Treatment Study Group.

AIDS Res Hum Retroviruses. 2010 Oct;26(10):1163-6. doi: 10.1089/aid.2010.0034. Epub 2010 Sep 21.

3.

Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.

Jourdain G, Wagner TA, Ngo-Giang-Huong N, Sirirungsi W, Klinbuayaem V, Fregonese F, Nantasen I, Techapornroong M, Halue G, Nilmanat A, Wittayapraparat P, Chalermpolprapa V, Pathipvanich P, Yuthavisuthi P, Frenkel LM, Lallemant M; Program for HIV Prevention and Treatment (PHPT) Study Group.

Clin Infect Dis. 2010 May 15;50(10):1397-404. doi: 10.1086/652148.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk